Comparison of coloninc cleansing methods for patients undergoing surgery of colorectal cancer
- Conditions
- colorectal cancer
- Registration Number
- JPRN-UMIN000016693
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Not provided
(1) Patients who have or who are suspected to have gastrointestinal obstruction (2) Patients who have or who are suspected to have gastrointestinal perforation (3) Patients who have or who are suspected to have toxic megacolon (4) Patients who have or who are suspected to have delayed gastric empty (5) Patients who have glucose-6-phosphate dehydrogenase deficiency (6) Patients who have renal dysfunction(blood urea nitrogen (BUN) >= 25 mg/dL, serum creatinine >= 2 mg/dL) (7) Patients who have gastrointestinal stenosis (8) Patients who have impaired vomiting reflex or risk of aspiration (9) Patients who are dehydrated (10) Patients who are under or need any treatments for severe cardiac disease (angina, cardiac infarction) or liver dysfunction (serum total bilirubin >= 3.0 mg/dL, ALT or AST >= 100 IU/L) (11) Patients who have allergy of the drugs (12) Patients who are pregnant or under lactation, or who would be expected to be pregnant during the study (13) Patients who are not eligible due to physician's judgment (14) Patients who are hospitalized for reasons other than taking colonoscopy (15) Patients who receive intravenous hyperalimentation or enteral nutrition
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method acceptability of colonic cleansing methods
- Secondary Outcome Measures
Name Time Method frequency of bowel movement, dose of standard and low-volume polyethylene glycol, Time to first defecation, duration of taking medicine, Time to start examination